本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Altimmune, Inc.

3.27
-0.0200-0.61%
盤後3.25-0.0187-0.57%19:48 EDT
成交量:270.47萬
成交額:892.29萬
市值:6.34億
市盈率:-4.30
高:3.41
開:3.33
低:3.26
收:3.29
52周最高:6.44
52周最低:2.56
股本:1.94億
流通股本:1.64億
量比:0.81
換手率:1.65%
股息:- -
股息率:- -
每股收益(TTM):-0.7600
每股收益(LYR):-0.9999
淨資產收益率:-28.87%
總資產收益率:-17.20%
市淨率:1.34
市盈率(LYR):-3.27

資料載入中...

2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/17

重要事件披露

8-K - Current report
2021/12/13

重要事件披露

8-K - Current report
2021/12/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/24

重要事件披露

8-K - Current report
2021/09/24

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/24

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/31

超過5%披露

Altimmune, Inc.
2021/08/31

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/10

重要事件披露

8-K - Current report
2021/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/29

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report